3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Radiotherapy
2
Practice Guidelines as Topic
2
Heavy Ion Radiotherapy
2
seocalcitol
1
pembrolizumab
1
Yoga
1
X-Rays
1
Tomography, Optical Coherence
1
Surveys and Questionnaires
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiofrequency Ablation
1
Pluvicto
1
Platinum Compounds
1
Pemetrexed
1
Nurses
1
Nivolumab
1
Nimorazole
1
NF protocol
1
Magnetic Resonance Spectroscopy
1
Lasers, Solid-State
1
Lasers, Gas
1
Itraconazole
1
Inulin
1
Interviews as Topic
1
Hearing
1
Fluorodeoxyglucose F18
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled